Investing.com -- Actinium Pharmaceuticals Inc (NYSE:ATNM) stock rose 3.7% on Friday following the presentation of new preclinical data for its breast cancer therapy candidate ATNM-400 at the 2025 San ...

Immunovant shifts primary focus to IMVT-1402, a next-generation anti-FcRn, targeting Graves' Disease with potential ...

Consistent OS benefit in an Asian subset with a strong HR of 0.69 for non-squamous patients, and meaningful safety advantage position Plinabulin ...

As part of what it described in the presentation as “radical automation goals,” Chubb aims to automate 85% of its major ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 11, 2025 ...

Discover how Frontier Firms scale AI to drive growth, efficiency, and innovation. Learn traits, strategies, and real-world ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ...

The presentation is available on the company’s website in the company documents section of the investor area, according to a press release statement. Kodal Minerals operates the Bougouni Lithium ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Week 48 endpoint analysis from the Company’s Phase 2 SOLSTICE trial for chronic hepatitis delta (CHD) ...

For years, I've watched bright and talented presenters falter when they step into the boardroom. They're often brimming with a wealth of data and a deck to prove it, but they miss the mark. The reason ...

Prezent, a startup that offers an AI-powered presentation builder to enterprises, said today that it has raised $30 million in funding led by Multiplier Capital, Greycroft, and Nomura Strategic ...